Documentos de Calpena A.C. | REDI

Regresar

Mostrando 4 resultados de: 4

Filtros aplicados

Palabras Claves: "PLGA-PEG"

Subtipo de publicación

Publisher

Nanomedicine: Nanotechnology, Biology, and Medicine(2)

Área temáticas

Enfermedades(4)

Farmacología y terapéutica(3)

Medicina y salud(2)

Fisiología humana(1)

Ginecología, obstetricia, pediatría, geriatría(1)

Área de conocimiento

Farmacología(3)

Descubrimiento de fármacos(1)

Nanopartícula(1)

Año de Publicación

Origen

Palabras Claves

Nanoparticles(3)

Alzheimer's disease(2)

Blood–Brain barrier(1)

Dexibuprofen(1)

Epigallocatechin-3-gallate(1)

Comparative study of Ex Vivo transmucosal permeation of pioglitazone nanoparticles for the treatment of Alzheimer's disease

Abstract: Pioglitazone has been reported in the literature to have a substantial role in the improvement of ov

Palabras claves:

Alzheimer's disease, Nanoparticles, Pioglitazone, PLGA-PEG, Transmucosal permeations

Calpena A.C., Espina M., García M.L., Halbaut L., Lupe Carolina Espinoza, Silva-Abreu M.

Epigallocatechin-3-gallate loaded PEGylated-PLGA nanoparticles: A new anti-seizure strategy for temporal lobe epilepsy

Abstract: Temporal lobe epilepsy is the most common type of pharmacoresistant epilepsy in adults. Epigallocate

Palabras claves:

Epigallocatechin-3-gallate, Epilepsy, PLGA-PEG, Polymeric nanoparticles

Antoni Camins, Auladell C., Barenys M., Calpena A.C., Cano A., Espina M., Ettcheto M., Folch J., García M.L., Sanchez-Lopez E.

New potential strategies for Alzheimer's disease prevention: pegylated biodegradable dexibuprofen nanospheres administration to APPswe/PS1dE9

Abstract: Dexibuprofen loaded pegylated poly(lactic-co-glycolic) nanospheres prepared by solvent diffusion met

Palabras claves:

Alzheimer's disease, Blood–Brain barrier, Dexibuprofen, Nanoparticles, Nanospheres, PLGA-PEG

Antoni Camins, Calpena A.C., Egea M.A., Espina M., Ettcheto M., Folch J., García M.L., Sanchez-Lopez E.

Memantine-Loaded PEGylated Biodegradable Nanoparticles for the Treatment of Glaucoma

Abstract: Glaucoma is a multifactorial neurodegenerative disease associated with retinal ganglion cells (RGC)

Palabras claves:

drug delivery, glaucoma, Memantine, Nanoparticles, PLGA-PEG

Antoni Camins, Calpena A.C., Cordeiro M.F., Davis B.M., Egea M.A., Espina M., Ettcheto M., García M.L., Guo L., Ravindran N., Sanchez-Lopez E., Silva A.M., Souto E.M.B.